LENZ Therapeutics, Inc. (NASDAQ: LENZ) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LENZ THERAPEUTICS, INC.

LENZ Therapeutics, Inc. (NASDAQ: LENZ)
Listen to this Section


$7.16
-0.0450 ( -0.63% ) 209.4K

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Market Data


Open $7.16
Previous Close $7.20
Volume 209.4K
Market Cap $219.79M
Day Range $7.10 - $7.34
52 Week Range $6.61 - $50.40
Shares Outstanding 31.35M
Change % -0.63%
Net Change ▼ -0.0450
Insider Ownership -0.03%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2024
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 2,396,861.00

Date Type Amount Purchased Purchaser
2025-11-10 Buy 10500.00 MCCOLLUM JAMES W
2025-11-10 Buy 10500.00 MCCOLLUM JAMES W
2025-11-07 Buy 20.00 Chevallard Daniel R.
2025-11-07 Buy 20.00 Chevallard Daniel R.
2024-07-23 Sale -45000.00 Schimmelpennink Evert B.
2024-05-15 Buy 3188.00 Chevallard Daniel R.
2024-05-14 Buy 31332.00 MCCOLLUM JAMES W
2024-03-25 Buy 2386301.00 RA CAPITAL MANAGEMENT, L.P.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 10, 2025
4 Insider transactions 1 Nov 07, 2025
8-k 8K-related 14 Nov 05, 2025
10-q Quarterly Reports 60 Nov 05, 2025
8-k 8K-related 12 Oct 08, 2025
4 Insider transactions 1 Oct 02, 2025
8-k 8K-related 14 Sep 30, 2025
4 Insider transactions 1 Sep 22, 2025
4 Insider transactions 1 Aug 26, 2025
4 Insider transactions 1 Aug 19, 2025

Latest News


× Before browsing our site, please accept our cookies policy